Pricing Log in Create free account

Edgewise Therapeutics, Inc. (EWTX) vs Travere Therapeutics, Inc. (TVTX)

Edgewise Therapeutics, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. Travere Therapeutics, Inc. is the larger, with a market value of $4.7B against $4.2B — 1.1× the size. Travere Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Edgewise Therapeutics, Inc. trades at 4.9×. Edgewise Therapeutics, Inc. has the higher net margin (0.00% vs −18.7%) and the higher return on invested capital (0.00% vs −54.1%). Across the 14 metrics below, Edgewise Therapeutics, Inc. leads on 9 and Travere Therapeutics, Inc. on 5.

Valuation

Metric EWTX TVTX Biotechnology median
P/E 4.85 n/m 10.60
P/S n/m 7.19 9.40
P/B 2.99 207.20 2.13
Price to free cash flow n/m 55.27 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 7.39 9.02
Earnings yield 20.61% (2.61%) (32.88%)
Free cash flow yield (4.14%) 1.81% (23.13%)

Profitability

Metric EWTX TVTX Biotechnology median
Gross margin 0.00% 98.53% 68.51%
Operating margin 0.00% (20.51%) 0.00%
Net margin 0.00% (18.66%) 0.00%
Free cash flow margin 0.00% 13.11% 0.00%
Return on equity 92.15% (252.75%) (51.96%)
Return on assets 85.43% (17.52%) (46.06%)
Return on invested capital 0.00% (54.08%) 0.00%

Growth

Metric EWTX TVTX Biotechnology median
Revenue growth (TTM) — 49.38% 6.76%
EPS growth (last fiscal year) (12.41%) 92.89% 29.88%
Revenue growth, 5-year CAGR — 19.87% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EWTX TVTX Biotechnology median
Debt to equity 0.00 26.72 0.00
Current ratio 12.30 3.00 4.97
Net debt to EBITDA 2.69 2.27 1.01

Dividend

Metric EWTX TVTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EWTX TVTX Biotechnology median
Market cap 4.22b 4.69b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack